Akari Therapeutics (AKTX) Cash & Equivalents Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.13% |
| Dec 31, 2025 | -75.35% |
| Sep 30, 2025 | -57.92% |
| Jun 30, 2025 | -26.62% |
| Mar 31, 2025 | -19.88% |
| Dec 31, 2024 | -14.58% |
| Sep 30, 2024 | -17.75% |
| Jun 30, 2024 | 8.82% |
| Mar 31, 2024 | -26.16% |
| Dec 31, 2023 | -8.25% |
| Jun 30, 2023 | -2.54% |
| Dec 31, 2022 | -13.96% |
| Jun 30, 2022 | -24.89% |
| Mar 31, 2022 | -13.28% |
| Dec 31, 2021 | -80.62% |
| Sep 30, 2021 | -27.94% |
| Jun 30, 2021 | -27.24% |
| Mar 31, 2021 | -35.86% |
| Dec 31, 2020 | 141.96% |
| Sep 30, 2020 | 29.92% |
| Jun 30, 2020 | 30.81% |
| Mar 31, 2020 | 42.56% |
| Dec 31, 2019 | 11.43% |
| Sep 30, 2019 | 157.60% |
| Jun 30, 2019 | -24.77% |
| Mar 31, 2019 | -15.47% |
| Dec 31, 2018 | 60.59% |
| Dec 31, 2017 | 91.06% |
| Dec 31, 2016 | 463.58% |